Skip to main content Back to Top
Advertisement

Lucas T. Schulz

Candidate for Director-at-Large 2021-2023

Section of Inpatient Care Practitioners
Lucas Schulz

LUCAS T. SCHULZ, Pharm.D., BCIDP (lschulz2@uwhealth.org), is Clinical Coordinator of Infectious Diseases and PGY2 ID Residency Program Director at University of Wisconsin Health. Schulz is also a Clinical Professor at the UWSchool of Pharmacy, contributing clinical rotations and clinical lectures in Pharmacotherapy. Previously, he practiced as a Critical Care Pharmacist in medical, surgical, and neurosurgical intensive care units at the University of Wisconsin Hospitals and Clinics. Schulz received his Pharm.D. degree from the University of Wisconsin School of Pharmacy. He completed a PGY1 and PGY2 critical care residency at the University of Wisconsin Hospital and Clinics. He is the author of 50 peer-reviewed publications and over 100 abstracts. In his current role, he leads an antimicrobial stewardship program recognized by The Joint Commission and Infectious Diseases Society of America as a Center of Excellence.

Lucas has been an active member of ASHP since 2003. He serves in the ASHP House of Delegates. He has participated in the ASHP New Practitioners Forum and ASHP Midyear Clinical Meeting as a moderator and presenter. Lucas supports the development of ASHP Board Certification in infectious diseases as reviewer. He is the residency program director of an ASHP accredited PGY2 infectious disease program since 2012. Lucas is also involved in leadership roles nationally and within the state of Wisconsin.

 

Inpatient pharmacy practice is and always has been ripe with opportunities to improve patient care, if we are willing to work together with physicians, nurses, and administrators and say “Yes” when asked to help. Antimicrobial use is universal to contemporary pharmacy practice settings, therefore, my work frequently takes me outside of the infectious disease and academic health-system spheres. In my experience developing robust antimicrobial stewardship programs, I partnered with large health systems, community hospitals, and critical-access hospitals to improve operational and clinical pharmacy services. Additionally, I coordinate with long-term care facilities, home infusion centers, specialty pharmacies, and other healthcare providers to provide exceptional patient care. Given the opportunity to serve as your Director-at-Large, I would advocate for solutions to problems faced by pharmacists across the continuum with a focus on the inpatient pharmacist. Participation in ASHP provides the support, resources, and advocacy needed to be a successful pharmacist in a multitude of practice settings. Working together with pharmacists from across the care continuum and saying, “Yes” when asked to step up to a new challenge placed me in positions to positively impact patient outcomes.

The ASHP Section of Inpatient Care Practitioners supports the development of frontline pharmacists interested in achieving optimal patient outcomes. As your Director-at-Large I want to serve ASHP members by identifying opportunities to develop pharmacist-led safe and effective care practices, lean into new challenges, like provider status, address burnout in our profession, and support pharmacists saying, “Yes” to improving patient care.